Election 2020: how politics shapes the pharma patent debate

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Election 2020: how politics shapes the pharma patent debate

Charlotte Kilpatrick
October 29 2020
us-election.jpg

With the US election less than one week away, Managing IP looks at how politics has attempted to chip away at patent rights in the pharma industry

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

IP StrategyUnited StatesNewsPatentsNorth AmericaJurisdictions
kilpatrick-charlotte-300px.png
Charlotte Kilpatrick
Reporter Managing IP
Contact
Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.
more from across site and SHARED ros bottom lb

More from across our site

Patents
shamilov-saina_hi-res_COVER.jpg
How Fenwick’s unblinking approach secured landmark ITC victory for Lashify
Saina Shamilov explains how she convinced the Federal Circuit to upend the US ITC’s domestic industry analysis
Rani Mehta, March 07 2025
Gift this article